Showing 302 news articles about PrEP policies & guidelines

Filters Content type: Editors' picks Topic: PrEP policies & guidelines

Health service and government policies on the licensing, provision and reimbursement of oral pre-exposure prophylaxis (PrEP). Expert guidelines, based on research evidence, to help clinicians provide care to PrEP users.

PrEP policies & guidelines

The Irish Times view on PrEP and HIV: A matter of urgency

Editor's pick
Irish Times
29 April 2019
Activism & civil society

How Activists Uncovered CDC's Ownership of Truvada PrEP Patents

Editor's pick
The Body
25 April 2019
Pharmaceutical industry

US: The Justice Department Is Looking Into Gilead’s PrEP Profits

Editor's pick
Out
25 April 2019
PrEP policies & guidelines

Ireland: Taoiseach and Minister for Health confirm introduction of PrEP programme in 2019

Editor's pick
Irish Ministry of Health
23 April 2019
PrEP policies & guidelines

Hivpoint Helsinki welcomes Pre-Exposure Prophylaxis – Finnish national guidelines are here, and generic medicines hit the market soon

Editor's pick
Hivpoint
17 April 2019
PrEP science

Letter to FDA Regarding Application for Descovy as Pre-Exposure Prophylaxis for HIV

Editor's pick
Treatment Action Group
17 April 2019
PrEP policies & guidelines

London councils agree to take 60% new PrEP trial patients, but it might not be enough

Editor's pick
Gay Star News
15 April 2019
PrEP policies & guidelines

London: Tower Hamlets Mayor calls for Government to fund PrEP for all to stop HIV transmission

Editor's pick
Tower Hamlets council
11 April 2019
PrEP policies & guidelines

PrEP: Camden councillor Jonathan Simpson urges NHS to extend availability of preventative HIV drug

Editor's pick
Ham & High
10 April 2019
PrEP science

Sticker Shock: PrEP Is Not Cost-Effective at Current Price, Health Economists Find

Editor's pick
The Body
9 April 2019
PrEP science

Gilead Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Once-Daily Descovy® for HIV Pre-Exposure Prophylaxis

Editor's pick
Gilead press release
8 April 2019
PrEP policies & guidelines

The CDC Director got shouted down by angry AIDS activists during a completely tone deaf speech

Editor's pick
LGBTQ Nation
5 April 2019
PrEP policies & guidelines

PrEP Impact Trial Update – April 2019

Editor's pick
NHS England
4 April 2019
PrEP policies & guidelines

Over the counter PrEP access raises concerns

Editor's pick
Bay Area Reporter
29 March 2019
Pharmaceutical industry

Taxpayers funded this HIV research. The government patented it. Now a company profits.

Editor's pick
Los Angeles Times
29 March 2019
PrEP policies & guidelines

Councils seek NHS funding to cover drug trial pressures

Editor's pick
Health Service Journal
27 March 2019
PrEP policies & guidelines

PrEP Pricing Is the Elephant in the Room at the CDC National HIV Prevention Conference

Editor's pick
The Body
24 March 2019
PrEP policies & guidelines

Rapidly Starting PrEP Before All Labs Are Back Proves Feasible in NYC

Editor's pick
Poz
21 March 2019
HIV prevention policy

LGBT+ health adviser urges Britain to make HIV-prevention drug free

Editor's pick
Reuters
18 March 2019
People & personal stories

Obituary: Mags Portman died on February 6th

Editor's pick
The Economist (requires free registration)
15 March 2019
PrEP science

Jean-Michel Molina, MD, on Biomedical Failures of PrEP: Rare, But Serious

Editor's pick
Contagion Live
14 March 2019
Government, leadership & policy

Trump’s Proposed Budget Undermines His H.I.V. Plan, Experts Say

Editor's pick
The New York Times
14 March 2019
PrEP policies & guidelines

Gilead's Descovy snared its PrEP data, but can it stand up to Truvada generics?

Editor's pick
FiercePharma
14 March 2019
PrEP policies & guidelines

Sadiq Khan: Cash row is denying Londoners access to HIV ‘wonder drug’

Editor's pick
Evening Standard
12 March 2019